Le Lézard
Classified in: Health, Science and technology
Subjects: FDA, FVT

Omron Healthcare Announces April 15th Pre-Order Availability of Completetm, the First Blood Pressure Monitor with EKG Capability


LAKE FOREST, Ill., April 11, 2019 /PRNewswire/ -- Omron Healthcare, Inc., the global leader in personal heart health and wellness technology, has secured FDA clearance on its new Completetm, the first blood pressure monitor with EKG capability in a single device, and will open pre-orders on April 15th at 12:00 pm CST in the U.S. on OmronHealthcare.com.

Completetm is the first blood pressure monitor with EKG capability in a single device.

Complete is an upper arm blood pressure monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. EKG readings can be measured by touching electrodes conveniently located on the top face and both sides of the monitor for easy access and comfort. EKG is an essential measurement for those with atrial fibrillation, also known as arrythmia or Afib1, a condition causing irregular heartbeat that can lead to heart health-related complications, including increased risk of stroke and heart failure.

"Millions of Americans are living with Afib and a stroke risk that is five times higher than average, and many others may not know they have this condition since it is difficult to diagnose. Recent studies2 predict that the number of individuals with Afib could reach epidemic levels as a result of the growing aging Baby Boomer population. Monitoring this condition and the risk it carries is part of our Going for Zero mission. That's why Omron developed Complete as an accessible, easy-to-use, at-home solution to provide a more complete heart health picture and greater peace of mind," said Ranndy Kellogg, president & CEO of Omron Healthcare, Inc.

Omron developed Complete in partnership with AliveCor, the market leader in FDA-cleared personal EKG technology. Complete uses the advanced new algorithm designed by AliveCor for improved detection of the possibility of Afib along with trusted medical-grade blood pressure measurement from Omron.

"Irregular heartbeat is unpredictable and can be difficult to detect without regular monitoring. The Omron Complete empowers anyone who suspects they might have arrythmia or has family history of the condition to monitor their status easily at home," said Kellogg.

Complete is the recent recipient of the iF Design Award 2019, presented by iF International Forum Design GmbH, one of the world's most prestigious design awards. This award was presented to Complete for its uniqueness, innovation, aesthetic appearance and performance.

Complete will be available for $199.99 (USD) pre-order only in the U.S. on OmronHealthcare.com, with retail availability expanding to Amazon beginning May 1, 2019.

About Omron Healthcare, Inc.

Omron Healthcare, Inc., is the world's leading manufacturer and distributor of personal heart health and wellness products. Its market-leading products include a full range of home blood pressure monitors and electrotherapy devices. Since Omron invented its first blood pressure monitors more than 40 years ago, the company has been passionate about empowering people to take charge of their health at home through precise technology. Omron is the number one doctor and pharmacist recommended brand of blood pressure monitors for home use. The company's mission is Going for Zero, the elimination of heart attacks and strokes. For more information, visit OmronHealthcare.com.

1 American Heart Association: What is Atrial Fibrillation (AFib or AF)? 
2 Journal of Geriatric Cardiology: Atrial Fibrillation: The Current Epidemic

Omron Healthcare (PRNewsfoto/Omron Healthcare, Inc.)

SOURCE Omron Healthcare, Inc.


These press releases may also interest you

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...

at 17:00
The Doctors Company, the nation's largest physician-owned medical malpractice insurer, announced today that it has approved a 2024 premium dividend of approximately $14.7 million, bringing the total of declared dividends to date to $470 million....

at 17:00
Northern Virginia Oral, Maxillofacial & Implant Surgery ("NOVA OMS") has learned of a data security incident that may have impacted data belonging to certain patients and guarantors. On October 5, 2023, NOVA OMS became aware of unusual activity on...



News published on and distributed by: